Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity

NCT01533779 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-02-15

No results posted yet for this study

Summary

Examine neutrophil extracellular traps (NETs) formation, in relation to other neutrophil functions like chemotaxis, superoxide production, hydrogen peroxide production, and the presence of myeloperoxidase, in pediatric patients undergoing chemotherpy for solid and hematological malignancies. This data could shed new light on the mechanism responsible for the increased susceptibility to infection among these patients and aid in improving their prophylactic antimicrobial treatment.

NETs formation against tumor cell lines and their ability to kill tumor cells will also be examined. The finding of NETs activity against tumor cells could have a major contribution to the investigators understanding of the function of the immune system against cancer.

Conditions

  • Pediatric Solid Malignancies
  • Pediatric Hematological Malignancies

Sponsors & Collaborators

  • Max Planck Institute for Infection Biology

    collaborator OTHER
  • Meir Medical Center

    collaborator OTHER
  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Sivan Achituv, MD · The department of pediatric hemato-oncology, Dana Childrens' Hospital, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01533779 on ClinicalTrials.gov